Literature DB >> 2418353

New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.

W S Colucci, R F Wright, E Braunwald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418353     DOI: 10.1056/NEJM198602063140605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  39 in total

Review 1.  Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.

Authors:  T J Torphy; B J Undem
Journal:  Thorax       Date:  1991-07       Impact factor: 9.139

2.  Acute Heart Failure Treatment.

Authors:  Phillip D Levy; Abdel Bellou
Journal:  Curr Emerg Hosp Med Rep       Date:  2013-06-01

3.  Selective blockade of nicotinic acetylcholine receptors by pimobendan, a drug for the treatment of heart failure: reduction of catecholamine secretion and synthesis in adrenal medullary cells.

Authors:  Yumiko Toyohira; Tatsuhiko Kubo; Miyabi Watanabe; Yasuhito Uezono; Susumu Ueno; Koji Shinkai; Masato Tsutsui; Futoshi Izumi; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-02-16       Impact factor: 3.000

4.  Introduction.

Authors:  Walter Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

Review 5.  The rationale for combined use of diuretics, digitalis, and vasodilators in congestive heart failure.

Authors:  T W Smith; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

6.  E-1020, a water soluble imidazopyridine, has direct effects on Ca(2+)-dependent force and ATP hydrolysis of canine and bovine cardiac myofilaments.

Authors:  F M Powers; K A Palmiter; R J Solaro
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

7.  Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.

Authors:  R R Reinhardt; E Chin; J Zhou; M Taira; T Murata; V C Manganiello; C A Bondy
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

9.  Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts.

Authors:  T Bethke; W Meyer; W Schmitz; H Scholz; B Stein; K Thomas; H Wenzlaff
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

10.  Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits.

Authors:  M Holbrook; S J Coker
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.